3Johnstone D, Berger C, Fleckman P, et al. Acute ful minant hepattis after treatment with rabeprazole and tebinafine[J]. Arch Intern MM .2001.161 : 1677.
5Tytgat GNJ. Shortcomings of the first-generation proton pump inhibitors[J]. Eur J Gastroenterol Hapatol, 2001,13 (Suppl 1):29.
6Sachs G, Shin JM. The Pharmacology of the gastric acid pump.The H^+ , K^+ ATPase[J]. Annu Rev Phamacol Toxicol, 1995,35 : 277.
7Besancon M,Simon A,Sachs G, et al. Sites of reaction of the gastric H^+ , K ^+ ATPase with extraytoplasmic thiol regents[ J ]. J Biol Chen, 1997,272 : 22438.
8Carswell CI ,Goa KL. Rabeprazole. an update of its use in acid-related disorders[J]. Drugs ,2001,61:2327.
9LangtryHD,Markham A. Rabeprazole:a review of its use in acidrelated gastrointestinal disorders[J]. Drugs, 1999,58 : 725.
10Prakash A, Faulds D. Rabeprazole[ J ]. Drugs, 1998,55 : 261.
7Shariat SF,Duchene D,Kabbani W. Gastrointestinal hemor-rhage as first manifestation of metastatic testicular tumor[J].Urolo-gy,2005,(06):1319.
8Elmunzer BJ,Inadomi JM,Elta GH. Risk stratification in upper gas-troin testinal bleeding[J].Journal of Clinical Gastroenterology,2007,(06):559-563.
9Kim Jm,Kim Js,Jung He. Distribution of antibiotic MICS for Helicobacter Pylori strains over a 16-year period in patients from Seoul,South Korea[J].Antimicrobial Agents and Chemotherapy,2004,(12):4843-4847.doi:10.1128/AAC.48.12.4843-4847.2004.
10Cover TL,Blaser MJ. Helicobacter pylori in health and disease[J].Gastroenterology,2009,(06):1863-1873.
